Piper Jaffray Updates Model on MedAssets (MDAS)

Piper Jaffray is out with its report today on MedAssets MDAS, updating its model on MDAS. In a note to clients, Piper Jaffray writes, "We are distributing operating expenses more evenly across quarters and updating Acquisition related charges to be less 1H heavy, while keeping the $25 million full year estimate. Our model changes do not change full year estimates for FY11 but do change quarterly earnings. Our Q1 cash earnings estimate decreases from $0.21 to $0.17 while Q3 and Q4 estimates increase by $0.03 and $0.02, respectively. FY11 cash EPS remains at $0.99. FY11 adjusted EBITDA also remains at $188.9 million but has become 2H'11 loaded. No Changes to FY11 revenues or FY12 estimates." Shares of MDAS closed Tuesday at $14.88.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care TechnologymedassetsPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!